target drug discovery (TargetD2)

See the following -

Industry Continues Dabbling with Open Innovation Models

Cormac Sheridan | Nature Biotechnology | December 8, 2011

On October 26, seven large pharma companies and a biotech firm, Alnylam, announced a collaboration with the World Intellectual Property Organisation (WIPO) to establish WIPO Re:Search. Read More »